Logo for BioLineRx Ltd

BioLineRx Investor Relations Material

Latest events

Logo for BioLineRx Ltd

Q3 2024

BioLineRx
Logo for BioLineRx

Q3 2024

25 Nov, 2024
Logo for BioLineRx

Q2 2024

15 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from BioLineRx Ltd

Access all reports
BioLineRx Ltd. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapeutics for oncology and rare diseases. The company's primary product pipeline includes therapies aimed at treating multiple myeloma, sickle cell disease, pancreatic cancer, and other solid tumors. BioLineRx leverages extensive drug development expertise to advance these therapies from preclinical stages through to commercialization. The company is headquartered in Hevel Modi'in, Israel, and its shares are listed on the NASDAQ.